-Reuters
AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug
AstraZeneca Plc (NASDAQ: AZN) has
Related Posts
Moleculin Biotech’s Annamycin In Leukemia Study Shows 80% Overall Response Rate
Moleculin Biotech Inc (NASDAQ:MBRX) provided an update on its clinical programs evaluating Annamycin for relapsed or refractory acute myeloid leukemia (AML)…
eHealth Q2 EPS $(1.15), Inline, Sales $50.41M Miss $72.77M Estimate
eHealth (NASDAQ:EHTH) reported quarterly losses of $(1.15) per share which met the analyst consensus estimate. This is a 155.56 percent decrease over losses of $(0.45) per share from the same period last year. The
Elon Musk: Twitter Ordered Whistleblower To Eliminate Critical Evidence After Failing ‘To Buy His Silence’
Tesla Inc (NASDAQ: TSLA) CEO Elon Musk reportedly accused Twitter Inc (NYSE: TWTR) of asking whistleblower Peiter "Mudge" Zatko to